Subscribe to this collection to receive daily e-mail notification of new additions

	Title	Author(s)	Issue Date
	Characterization of the tumor suppressive role of DESC1 in esophageal squamous cell carcinoma Proceeding/Conference:Research Postgraduate Symposium, RPS 2013	Ng, HYLung, ML	2013
	Nasopharyngeal carcinoma candidate tumor-suppressive ECM protein, LTBP2, mediates its effects via the pleiotropic transcription factor NF-κB pathway Proceeding/Conference:Research Postgraduate Symposium, RPS 2013	Kan, PQRCheung, AKLLung, ML	2013
	DNAJB6a as tumor suppressor in esophageal squamous cell carcinoma Proceeding/Conference:Cancer Research	Yu, VZWong, VCLChan, KWLung, ML	2014
	Identification of candidate epigenetic markers for early detection of nasopharyngeal carcinoma Proceeding/Conference:Research Postgraduate Symposium, RPS 2013	Yang, XDai, WSzeto, CYYCheng, YKwong, DLWLung, ML	2013
	Feasibility of 90Y bremsstrahlung scan to determine SIRT patient dose Proceeding/Conference:RSNA 2013 Scientific Assembly & Annual Meeting	Ng, CYLaw, WMLee, VHFMa, WLeung, TW	2013
	Advances in Nasopharyngeal Carcinoma: Chemotherapy and Targeted Therapy	Sham, JST	2012
	Personalized medicine and targeted therapy Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2013	Ho, JCMLee, VHF	2013
	Epithelial-Mesenchymal Transition (EMT) and HCC Metastasis Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2011	Guan, X	2011
	Host-pathogen attributes of oral candidiasis in nasoharyngeal carcinoma patients Proceeding/Conference:IADR-SEA 2011	Leung, CHSeneviratne, CLee, HWong, SSamaranayake, LP	2011
	Capecitabine but not 5-FU worsened hepatosplenomegaly and liver function when used with oxaliplatin and cetuximab as first-line treatment in K-ras wild-type metastatic colorectal cancer Proceeding/Conference:Journal of Clinical Oncology	Lee, VHFFang, WJLam, KOChoi, CWNg, SCYHo, PPYHo, GCLCheng, TKCLiu, RKYLeung, TWKwong, DLWZheng, S	2013
	Efficacy and toxicity of reirradiation using Intensity Modulated Radiotherapy for recurrent or second primary nasopharyngeal carcinoma Proceeding/Conference:International Journal of Radiation: Oncology - Biology - Physics	Ho, PChua, DTTWong, LSLee, VHFLeung, TW	2012
	Re-treatment of nasopharyngeal carcinoma by sequential chemo-radiotherapy with or without cetuximab Proceeding/Conference:International Journal of Radiation Oncology - Biology - Physics	Chua, DLee, VTsang, JNg, SCYLeung, TWAu, GKH	2009
	Impact of intravenous contrast used in computed tomography (CT) scan on dose to the carotids and thyroid in IMRT planning for nasopharyngeal carcinoma (NPC) Proceeding/Conference:International Journal of Radiation: Oncology - Biology - Physics	Lee, VKwong, DLWNg, SCYLeung, TWAu, GKH	2010
	A randomized Phase II study of external beam reirradiation versus external beam reirradiation plus radiosurgery boost in recurrent nasopharyngeal carcinoma Proceeding/Conference:International Journal of Radiation: Oncology - Biology - Physics	Chua, DHo, PLee, VSham, JST	2011
	Whole-brain radiotherapy with simultaneous integrated boost using volumetric modulated arc therapy (VMAT) for patients of recursive partitioning analysis (RPA) class I and II suffering from 1-3 brain metastases Proceeding/Conference:RCR-HKCR 2013 Joint Scientific Meeting & 21st ASM of HKCR	Lee, VHFNg, CYTaw, BTBHung, KNLam, KOChan, WWLLeung, DKCHo, PPYSze, CKHLeung, TWKwong, DLW	2013
	Biweekly cetuximab and first-line chemotherapy in Chinese patients with K-RAS wild-type colorectal cancers Proceeding/Conference:Annual Scientific Meeting of the Hong Kong College of Radiologists, HKCR 2012	Chan, WLWLee, VHFHo, PPYLeung, DKCWong, LSSiu, SWKLiu, KYLeung, TW	2012
	A randomized placebo-controlled phase III study of intercalated erlotinib with gemcitabine/platinum in first-line advanced non-small cell lung cancer (NSCLC): FASTACT-II Proceeding/Conference:Journal of Clinical Oncology	Mok, TWu, YLThongprasert, SYu, CJZhang, LLadrera, GESrimuninnimit, VSriuranpong, VSandoval-Tan, JZhu, YLiao, MZhou, CPan, HLee, VChen, YMSun, YMargono, BJin, KTruman, MLee, JS	2012
	Predictors of treatment outcome in patients treated with radical chemoradiotherapy for stage III Non-small Cell Lung Cancer Proceeding/Conference:Annual Scientific Meeting of the Hong Kong College of Radiologists, HKCR 2012	Chan, WLLee, VHFChoy, TSHo, PPYLeung, DKCWong, LSLam, KOKwong, DLWLeung, TW	2012
	Phase II study of two eribulin regimens in combination with erlotinib in patients (PTS) with previously treated advanced non-small cell lung cancer (NSCLC) Proceeding/Conference:Annals of Oncology	Geater, SLIanotti, NThongprasert, SSpira, ASmith, DLee, VLim, WTGopalakrishna, PReynolds, CMok, TSK	2012
	The PBL Experiences in Scientific & Health Education at University Level with English as a Second Language Proceeding/Conference:International Conference of Education, Research and Innovation ICERI 2012 Proceedings	Lau, YMLeung, JKCLee, VHF	2012